| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
,¶,||,¶
* Integrated Department of Immunology, National Jewish Medical and Research Center, and University of Colorado Health Sciences Center, Denver, CO 80262; and
Department of Pediatrics,
Department of Microbiology, and
Department of Internal Medicine,
¶ Holden Cancer Center, University of Iowa and
|| Veterans Affairs Medical Center, Iowa City, IA 52242
Members of the TNFR family play critical roles in the regulation of the immune system. One member of the family critical for efficient activation of T-dependent humoral immune responses is CD40, a cell surface protein expressed by B cells and other APC. The cytoplasmic domain of CD40 interacts with several members of the TNFR-associated factor (TRAF) family, which link CD40 to intracellular signaling pathways. TRAF2 and 6 appear to play particularly important roles in CD40 signaling. Previous studies suggest that the two molecules have certain overlapping roles in signaling, but that unique roles for each molecule also exist. To better define the roles of TRAF2 and TRAF6 in CD40 signaling, we used somatic cell gene targeting to generate TRAF-deficient mouse B cell lines. A20.2J cells deficient in TRAF6 exhibit marked defects in CD40-mediated JNK activation and the up-regulation of CD80. Our previous experiments with TRAF2-deficient B cell lines suggest that TRAF6 and TRAF2 may have redundant roles in CD40-mediated NF-
B activation. Consistent with this hypothesis, we found CD40-mediated activation of NF-B intact in TRAF6-deficient cells and defective in cells lacking both TRAF2 and TRAF6. Interestingly, we found that TRAF6 mutants defective in CD40 binding were able to restore CD40-mediated JNK activation and CD80 up-regulation in TRAF6-deficient cells, indicating that TRAF6 may be able to contribute to certain CD40 signals without directly binding CD40.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by an American Heart Scientist Development Grant (to B.S.H.). J.M.E. was supported by National Institutes of Health Grant T32 HL07344. G.A.B. was supported by National Institutes of Health Grants AI28847, AI49993, and CA099997 and a Veterans Affairs Career Award.
2 S.L.R. and M.M.T. contributed equally to this study.
3 Address correspondence and reprint requests to Dr. Bruce Hostager, Department of Pediatrics, University of Iowa, 4-204 Medical Education and Research Facility, Iowa City, IA 52242. E-mail address: bruce-hostager{at}uiowa.edu
4 Abbreviations used in this paper: TRAF, TNFR-associated factor; IKK, IB kinase; IPTG, isopropyl-
-D-thiogalactopyranoside; RSV, Rous sarcoma virus.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
